Anzeige
Mehr »
Login
Sonntag, 26.09.2021 Börsentäglich über 12.000 News von 673 internationalen Medien
LUKRATIVE NEUVORSTELLUNG IM MEGA-WACHSTUMSMARKT
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
347 Leser
Artikel bewerten:
(2)

DNA Brands Inc.: DNA Brands Reduces Common Shares Authorized

FORT LAUDERDALE, FL / ACCESSWIRE / March 9, 2021 / (OTC PINK:DNAX) DNA Brands Inc. is pleased to inform the public, the company has decreased it's common shares authorized from 3.7 Billion to Twenty Million (20,000,000), which also accounts for the company's recent Form 1-A application for a Ten million share offering under rule Reg A.

Management believes this update better reflects the company's current market capitalization and management's commitment to Anti-Dilution.

Currently as it stands the share structure is the following:

Approx: 6,500,000 Issued and outstanding , of which management owns 3.5 million shares.

Reg A - 10,000,000 Shares on reserve (Upon Qualification).

Approx: 2.5-3 Million shares in the Float (public hands).

About DNA Brands, Inc.

DNA Brands is a Holding company. It owns all the IP of DNA Energy. A two time award winning Energy Drink. In March 2020, the company acquired 954Solar LLC and has been engaged in Solar Digital Marketing and Sales. Also with the recent Acquisition of DNATags® in January 2021, the company now owns 2 pieces of Intellectual property, and will begin marketing DNATags® to both the medicinal and recreational Cannabis Industry.

Adrian M Patasar
info@dnabrandsinc.com
561-654-5722

Forward looking statements

This press release contains forward-looking statements within the meaning of the federal securities laws. All statements other than statements of historical fact included in this presentation are forward-looking statements. These statements relate to analyses and other information, which are based on forecasts of future results and estimates of amounts not yet determinable. These statements also relate to our future prospects, developments, and business strategies. These forward-looking statements may be identified by the use of terms and phrases such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "plan," "predict," "project," "target," "will" and similar terms and phrases, including references to assumptions. However, these words are not the exclusive means of identifying such statements. Although we believe that our plans, intentions, and expectations reflected in or suggested by such forward-looking statements are reasonable, we cannot assure you that we will achieve those plans, intentions, or expectations. All forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those that we expected or may prove unachievable. The forward-looking statements included in this press release are made only as of the date hereof. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events, or otherwise, except as otherwise required by law.

SOURCE: DNA Brands Inc.



View source version on accesswire.com:
https://www.accesswire.com/634312/DNA-Brands-Reduces-Common-Shares-Authorized

Kostenloser Wertpapierhandel auf Smartbroker.de
© 2021 ACCESSWIRE
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.